CREB1 is activated in breast cancer and modulates the transcription of Tacstd2. At the same time, the activation of Tacstd2 increases the cytoplasmic calcium (Ca2+) level, which could in turn activate CREB1 through calmodulin-dependent protein kinases (e.g. CaMKII). Here, CREB1 is linked to breast carcinoma.